Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-25 @ 4:27 AM
NCT ID: NCT01096420
Eligibility Criteria: Inclusion Criteria: * Age 18 to 75 years old * Patients were required to have a diagnosis of chronic migraine with or without medication overuse that satisfied the ICHD-2 criteria during the last 3 months prior to trial entry, with an established migraine history for at least 1 year. Exclusion Criteria: * Patients did not fulfill the criteria of ≧ 15 days or response to triptans or ergots on at least 8 days in prospective baseline periods . * The presence of headaches other than chronic migraine (such as another primary chronic headache or any secondary headache). * Migraine prophylaxis agents during last 3 months including β-blockers, anti-depressants, calcium channel blockers, anti-epileptic agents or cycle-modulating hormonal drugs. * Migraine onset after age 50 or the age at onset of CM \> 60 years. * History of hepatic disorder, nephrolithiasis or other severe illness. * Cognitive impairment interfering with the subject's ability to follow instructions and describe symptoms. * Prior fearful experience of acupuncture. * Bleeding diathesis or anticoagulation. * Pregnant or nursing.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 75 Years
Study: NCT01096420
Study Brief:
Protocol Section: NCT01096420